Trial description:
International randomised phase II trial of the combinations of Vincristine and Irinotecan with or without Temozolomide (VI or VIT) in patients with refractory of relapsed rhabdomyosarcoma
Contact name:
Dr Helen Hatcher
Trial start date:
Thursday, June 20, 2013
Trial end date:
Saturday, August 11, 2018
Trial tumour type:
Sarcoma
Show on Radiotherapy:
No
